Direkt zum Inhalt
Merck

APOMAG-62K

Millipore

MILLIPLEX® Human Apolipoprotein Magnetic Bead Panel - Cardiovascular Disease Multiplex Assay

This Bead-Based Multiplex Assay, using the Luminex® xMAP® technology, enables the simultaneous analysis of Apo AI, Apo AII, Apo B, Apo CII, Apo CIII, Apo E.

Synonym(e):

human apolipoprotein CVD immunoassay panel, luminex human apolipoprotein cardiovascular disease multiplex assay, millipore human apolipoprotein CVD multiplex kit

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

UNSPSC-Code:
12161503
eCl@ss:
32161000
NACRES:
NA.84

Leistungsmerkmale

This Bead-Based Multiplex Assay, using the Luminex® xMAP® technology, enables the simultaneous analysis of Apo AI, Apo AII, Apo B, Apo CII, Apo CIII, Apo E.

Qualitätsniveau

Speziesreaktivität

human

Hersteller/Markenname

Milliplex®

assay range

accuracy: 85%
(Apo E)

accuracy: 86%
(Apo AI)

accuracy: 89%
(Apo CIII)

accuracy: 92%
(Apo B)

sensitivity: 1.00 ng/mL
(Apo AII)

sensitivity: 1.22 ng/mL
(Apo CII)

sensitivity: 1.42 ng/mL
(Apo E)

sensitivity: 1.48 ng/mL
(Apo AI)

sensitivity: 1.71 ng/mL
(Apo CIII)

sensitivity: 4.84 ng/mL
(Apo B)

Methode(n)

multiplexing: suitable

Nachweisverfahren

fluorometric (Luminex xMAP)

Versandbedingung

wet ice

Allgemeine Beschreibung

Metabolic Syndrome has received increased attention from the medical community with increasing cases of obesity, type 2 diabetes and related cardiovascular diseases being described and studied.

MILLIPLEX® Human Apolipoprotein Panel is a 6-plex kit to be used for the simultaneous quantification of any or all of the following analytes in serum, plasma, tissue culture supernatant or other biological samples: APOA-1, APOA-2, APOB, APOC-2, APOC-3, and APOE. This kit uses a 96-well format, contains a lyophilized standard cocktail, two internal assay quality controls and can measure up to 38 samples in duplicate.

The Luminex® xMAP® platform uses a magnetic bead immunoassay format for ideal speed and sensitivity to quantitate multiple analytes simultaneously, dramatically improving productivity while conserving valuable sample volume.

Panel Type: Cardiovascular

Spezifität

Cross Reactivty
To test cross-reactivity among the assays in the panel, individual apolipoprotein standard was prepared at a concentration 4 times greater than the highest concentration in the calibration curve and tested in the 6-plex assays with multiplexed beads containing immobilized capture antibodies and individual detection antibodies. There was negligible cross-reactivity within the panel.

Anwendung

  • Analytes: Apo AI, Apo AII, Apo B, Apo CII, Apo CIII, Apo E
  • Recommended Sample Type: Human serum, plasma, tissue culture supernatant or other biological samples
  • Recommended Sample Dilution: 10 μL of a 1: 4,000 dilution of plasma or serum
  • Assay Run Time: Primary incubation of 1 hour followed by a secondary incubation of 30 minutes, both at room temperature (20-25°C)
  • Research Subcategory: Cardiovascular Disease

Leistungsmerkmale und Vorteile

Design your multiplex kit by choosing available analytes within this panel.

Sonstige Hinweise

Please contact Technical Service for linearity of dilution.
Standard curve range: Refer to the kit protocol for details.

Rechtliche Hinweise

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Haftungsausschluss

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Signalwort

Danger

Gefahreneinstufungen

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

Zielorgane

Respiratory Tract

Lagerklassenschlüssel

10 - Combustible liquids

WGK

WGK 3


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Consumption of buckwheat modulates the post-prandial response of selected gastrointestinal satiety hormones in individuals with type 2 diabetes mellitus.
Stringer, DM; Taylor, CG; Appah, P; Blewett, H; Zahradka, P
Metabolism, Clinical and Experimental null
Elise Grytten et al.
Clinical nutrition (Edinburgh, Scotland), 40(5), 2556-2575 (2021-05-03)
Marine-derived omega-3 (n-3) polyunsaturated fatty acids (PUFAs), mainly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), lower circulating levels of triacylglycerols (TAGs), and the plant-derived omega-6 (n-6) PUFA linoleic acid (LA) may reduce cholesterol levels. Clinical studies on effects of these
Yi-Ting Chen et al.
Molecular & cellular proteomics : MCP, 16(5), 799-811 (2017-02-27)
Multiple (selected) reaction monitoring (MRM/SRM) of peptides is a growing technology for target protein quantification because it is more robust, precise, accurate, high-throughput, and multiplex-capable than antibody-based techniques. The technique has been applied clinically to the large-scale quantification of multiple
Xiaoke Yin et al.
Circulation. Cardiovascular genetics, 10(6) (2017-12-15)
Mass spectrometry is selective and sensitive, permitting routine quantification of multiple plasma proteins. However, commonly used nanoflow liquid chromatography (LC) approaches hamper sample throughput, reproducibility, and robustness. For this reason, most publications using plasma proteomics to date are small in
Anastasiia S Boiko et al.
Heliyon, 5(7), e02033-e02033 (2019-07-19)
Schizophrenia is associated with a lowered life expectancy due to cardiovascular disease. This is, at least in part, related to an increased vulnerability to the development of metabolic syndrome (MetS) in patients with schizophrenia. The dysregulation of apolipoproteins (Apos) may

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.